Evidence map›Paper›PMID 26846577›Full record

ArticleMolecular medicine reports2016

The hypoxia-mimetic agent CoCl₂ induces chemotherapy resistance in LOVO colorectal cancer cells.

Guanglei Yang, Shuqing Xu, Lintao Peng, Hui Li, Yan Zhao, Yanfang Hu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guanglei YangDepartment of General Surgery, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai, Hebei 054031, P.R. China.
Shuqing XuDepartment of General Surgery, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai, Hebei 054031, P.R. China.
Lintao PengDepartment of General Surgery, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai, Hebei 054031, P.R. China.
Hui LiThe Medical Department, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai, Hebei 054031, P.R. China.
Yan ZhaoDepartment of Pathogenic Biology, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China.
Yanfang HuDepartment of Neurology, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai, Hebei 054031, P.R. China.
Hebei Medical University · CNXingtai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia, which is an important factor that mediates tumor progression and poor treatment response, is particularly associated with tumor chemoresistance. However, the molecular mechanisms underlying hypoxia-induced colorectal cancer chemoresistance remain unclear. The present study aimed to explore the mechanism underlying hypoxia‑induced chemotherapy resistance in LOVO colorectal cancer cells. LOVO cells were cultured in a hypoxic environment simulated by cobalt chloride (CoCl2), which is a chemical inducer of hypoxia‑inducible factor‑1α (HIF‑1α). HIF‑1α is a transcription factor that has an important role in tumor cell adaptation to hypoxia, and controls the expression of several genes. Various CoCl2 concentrations are often used to simulate degrees of hypoxia. In the present study, following treatment with CoCl2, an MTT assay was conducted to determine the growth and drug sensitivity of LOVO cells. Reverse transcription‑polymerase chain reaction and western blotting were used to detect the mRNA and protein expression levels of HIF‑1α and factors associated with chemotherapy resistance, including multidrug resistance protein (MRP) and multidrug resistant 1 (MDR1), which encodes the major transmembrane efflux transporter P‑glycoprotein (P‑gp). In addition, the expression levels of apoptosis‑related proteins, including B‑cell lymphoma 2 (Bcl‑2), Bcl‑2‑associated X protein (Bax) and Bcl‑2‑associated agonist of cell death (Bad) were detected by western blotting. Flow cytometry (FCM) was used to visually observe Adriamycin (ADR) accumulation and retention, thus analyzing intracellular drug transportation in cells under hypoxic and normoxic conditions. CoCl2‑simulated hypoxia was able to inhibit tumor cell proliferation, and upregulate the expression levels of HIF‑1α, MDR1/P‑gp and MRP. In addition, proapoptotic members of the Bcl‑2 protein family, Bax and Bad, were downregulated. The anti‑apoptotic member Bcl‑2 exhibited no significant change in expression, whereas the ratio of Bcl‑2/Bax was increased. Results of FCM demonstrated that the intracellular retention of ADR was significantly decreased in the hypoxia group cells. In conclusion, the present study revealed that a CoCl2-simulated hypoxic microenvironment was able to effectively induce chemoresistance and reduce apoptosis in LOVO cells.

Indexed as

bcl-2-Associated X Proteinbcl-Associated Death ProteinCell HypoxiaCell Line, TumorCell ProliferationCobaltColorectal NeoplasmsDown-RegulationDoxorubicinDrug Resistance, NeoplasmFluorouracilHumansReal-Time Polymerase Chain ReactionTetrazolium SaltsThiazolesBAD protein, humanBAX protein, humanbcl-2-Associated X Proteinbcl-Associated Death ProteinCobaltcobaltous chlorideDoxorubicinFluorouracilTetrazolium SaltsThiazolesthiazolyl blue

Identifiers

PMID26846577
PMCPMC4768964
OpenAlexW2261041965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.